NDC 13668-0014 - Levetiracetam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13668-0014
- Manufacturer
- Rebel Distributors Corp
- Effective date
- 2010-09-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levetiracetam - Rebel Distributors Corp | Rebel Distributors Corp | 2010-09-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LEVETIRACETAM | ACTIVE INGREDIENT | 44YRR34555 | LEVETIRACETAM TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| LEVETIRACETAM | ACTIVE MOIETY | 44YRR34555 | LEVETIRACETAM TABLET [REBEL DISTRIBUTORS CORP] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levetiracetam | LEVETIRACETAM | A-S Medication Solutions | 671a1ae1-f672-48da-8a69-94c147472003 | 2025-10-16 | Warnings, Adverse reactions | 311289 44YRR34555 |
| Spritam | LEVETIRACETAM | Aprecia Pharmaceuticals, LLC | be651c31-383f-11e4-916c-0800200c9a66 | 2025-10-13 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | PD-Rx Pharmaceuticals, Inc. | 792db8dc-177b-4864-8600-12823819082d | 2025-10-08 | Warnings, Adverse reactions | 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Quallent Pharmaceuticals Health LLC | 3756f052-919c-4817-a56e-1091fd514d9d | 2025-10-07 | Warnings, Adverse reactions | 311288 387003 311290 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | NorthStar RxLLC | 3884cb76-822b-400d-9b24-49c286c9b6f7 | 2025-10-07 | Warnings, Adverse reactions | 311288 387003 311290 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | SOHM, Inc. | 0a688786-879b-4e27-a46a-5c86bbfa1292 | 2025-09-19 | Warnings, Adverse reactions | 311288 387003 311290 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Major Pharmaceuticals | c4b27429-50a3-467c-a5ff-7e49a01a1088 | 2025-09-11 | Warnings, Adverse reactions | 311288 311290 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Precision Dose, Inc. | 6fb1e4d3-520c-44f1-a09d-d7b779e4edfd | 2025-09-03 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Rising Pharma Holdings, Inc. | db423b93-d7c2-4cf2-829b-24b657f27f93 | 2025-08-20 | Warnings, Adverse reactions | 311288 387003 311290 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Preferred Pharmaceuticals, Inc. | e31c6830-4647-4481-b4f1-494a52c48b1b | 2025-07-11 | Warnings, Adverse reactions | 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Prasco Laboratories | dd175fa3-1d7a-4542-affd-988ac5bba1db | 2025-07-01 | Warnings, Adverse reactions | 44YRR34555 |
| Keppra | LEVETIRACETAM | UCB, Inc. | c6d5784d-abf9-45fe-ac5a-d5c53bd50f7e | 2025-06-30 | Warnings, Adverse reactions | 44YRR34555 |
| Keppra XR | LEVETIRACETAM | UCB, Inc. | 2919e43b-69a8-434c-a2d2-1f3ecd7554c0 | 2025-06-24 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM IN SODIUM CHLORIDE | Caplin Steriles Limited | 563171fb-df26-4f95-853a-fd7707da291c | 2025-06-24 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | OWP Pharmaceuticals, Inc. | e662bf5b-c81c-4bcd-ba2e-552df95ca6f9 | 2025-05-15 | Warnings, Adverse reactions | ANDA078858 311288 387003 311290 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Hikma Pharmaceuticals USA Inc. | 097e5606-dd5e-4518-ab97-f71f68786444 | 2025-05-01 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Civica, Inc. | 1591c690-f4ed-44b7-a9d0-bff1fbb4bfef | 2025-05-01 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Mylan Pharmaceuticals Inc. | 0a987d59-560f-4650-96ec-31aec81953b5 | 2025-04-12 | Warnings, Adverse reactions | 387003 311290 311289 44YRR34555 |
| LEVETIRACETAM | LEVETIRACETAM | QUAGEN PHARMACEUTICALS LLC | 1d67cb3c-1173-4dce-a79b-a3c36934ab2e | 2025-04-03 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Hikma Pharmaceuticals USA Inc. | 8d767545-1eb9-45a5-bd16-e8a66e628fea | 2025-04-01 | Warnings, Adverse reactions | 44YRR34555 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.